Moorooka, Australia

Norbert Wimmer

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Norbert Wimmer

Introduction: Norbert Wimmer, an accomplished inventor based in Moorooka, Australia, has made significant contributions to the field of biomedical research through his innovative work. With a focus on sulfated oligosaccharide derivatives, Wimmer has been instrumental in developing novel compounds with diverse therapeutic applications.

Latest Patents: Wimmer holds two patents related to sulfated oligosaccharide derivatives. His latest invention pertains to compounds that serve as inhibitors of heparan sulfate-binding proteins. These compounds and their compositions can be utilized for various medical treatments, including antiangiogenic, antimetastatic, anti-inflammatory, antimicrobial, anticoagulant, and antithrombotic therapies, aimed at improving the health of mammalian subjects.

Career Highlights: Throughout his career, Norbert Wimmer has worked with prominent companies such as Progen Pharmaceuticals and Progen PG500 Series Pty Ltd. His dedication to research and innovation has led to the successful development of patents that hold great promise in the medical field.

Collaborations: In his journey as an inventor, Wimmer has collaborated with esteemed colleagues including Vito Ferro and Tomislav Karoli. Their collective expertise has likely enriched the research and development processes behind his innovative patents.

Conclusion: Norbert Wimmer's inventive spirit and dedication to advancing biomedical solutions make him a remarkable figure in the innovation landscape. Through his patents and collaborations, Wimmer continues to pave the way for future developments in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…